In 2005, the same year, the US FDA approved Nexavar (sorafenib), a drug for the treatment of advanced renal cell carcinoma, jointly developed by Bayer HealthCare and Onyx Pharmaceuticals.

The oncolytic virus therapy – also being developed by French biotech Transgene – failed to show any additional benefit when added to treatment with Bayer/Amgen’s targeted therapy Nexavar ...

Breast carcinoma remains the most common malignancy of women around the world, and despite the advances in the early diagnosis and adjuvant treatment of this disease, many women still relapse with ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Future Rheumatol. 2008;3(2):153-159. © 2008 Future Medicine Ltd. No writing assistance was utilized in the production of this manuscript. Gaëlle Clavel, Inserm ...

Julian Alvarez scored a second-half brace as a 10-man Atletico Madrid came from a goal down to beat Bayer Leverkusen 2-1 at home on Tuesday, and take a major step towards a top-eight finish.

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

At close: February 7 at 9:52:02 PM GMT+1 ...